RXR agonist, 9-cis-13,14-dihydroretinoic acid (9CDHRA), reduces damage and protects from demyelination in transsynaptic degeneration model
Article in Neuroscience (August 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Article in Neuroscience (August 2024)
Preprint in bioRxiv (March 2024)
Preprint in bioRxiv (February 2024)